Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse., M Kamanaka, ...
... and glycosylation site are required for agouti activity in vivo. In contrast, no biological activity has been ascribed to the ... Gene-Dosage, Gene-Expression, Glycosylation, Mice, Mice-Transgenic, Mutation, Obesity, Phenotype, Pigmentation, Promoter- ... and glycosylation site are required for agouti activity in vivo. In contrast, no biological activity has been ascribed to the ...